Regulatory approval and a first‐in‐human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants

Although plant biotechnology has been widely investigated for the production of clinical‐grade monoclonal antibodies, no antibody products derived from transgenic plants have yet been approved by pharmaceutical regulators for clinical testing. In the Pharma‐Planta project, the HIV‐neutralizing human...

Full description

Saved in:
Bibliographic Details
Published in:Plant biotechnology journal Vol. 13; no. 8; pp. 1106 - 1120
Main Authors: Ma, Julian K‐C, Drossard, Jürgen, Lewis, David, Altmann, Friedrich, Boyle, Julia, Christou, Paul, Cole, Tom, Dale, Philip, van Dolleweerd, Craig J, Isitt, Valerie, Katinger, Dietmar, Lobedan, Martin, Mertens, Hubert, Paul, Mathew J, Rademacher, Thomas, Sack, Markus, Hundleby, Penelope A. C, Stiegler, Gabriela, Stoger, Eva, Twyman, Richard M, Vcelar, Brigitta, Fischer, Rainer
Format: Journal Article
Language:English
Published: England Blackwell Pub 01.10.2015
John Wiley & Sons, Inc
Subjects:
ISSN:1467-7644, 1467-7652
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first